AMFI Registered MFD · ARN-130934 · Mutual fund investments are subject to market risks. CA Amit Kumar Jain · +91 93522 44475 Poornima Jain · +91 92525 44475 support@plenitude.co.in हिंदी

Fabtech Technologies Limited share price

Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.Read more

WebsiteNSEहिंदी मेंBSE

HealthcareHealth Information ServicesNSE: FABTECHISIN INE0HF201011
16 Oct 2026, 3:29 PM IST₹130.30▼ 1.81 (1.37%)
  • Market Cap₹ 579 Cr.
  • Current Price₹ 130.30
  • High / Low₹ 263 / 129
  • Stock P/E10.6
  • Book Value₹ 109
  • Dividend Yield0.45 %
  • ROCE11.8 %
  • ROE12.90 %
  • Face Value₹ 10.0
More figures (10)
  • EPS (TTM)₹ 12.33
  • Price / Book1.19
  • OPM7.7 %
  • Debt / Equity0.17
  • Sales growth (3Y)28.3 %
  • Profit growth (3Y)20.8 %
  • Promoter holding72.0 %
  • EV / EBITDA8.4
  • Beta—
  • All-time high₹ 263

Price chart

Returns1M3M6MYTD1Y3Y CAGR5Y CAGR
FABTECH-10.55%-16.82%-16.92%-33.76%-29.24%——
Nifty 50-0.31%-3.85%-4.34%-11.42%-9.53%+5.46%+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

  • Fabtech Technologies Limited is in the Health Information Services industry (Healthcare), with a market value of ₹579 crore.
  • It trades at 10.6 times its last 12 months' earnings and 1.2 times book value.
  • Revenue grew 28.3% a year over the last 3 years, profit 20.8% a year.
  • Return on equity was 12.9% and return on capital employed 11.8% in the latest year.
  • Debt was 0.17 times shareholders' equity.
  • The share price is 50.4% below its 52-week high and down 29.2% over one year.
  • Promoters and insiders hold about 72.0%; institutions about 1.2%.

Pros

  • Strong return on equity: 22.7% on average over the last 3 years.
  • Borrowings are moderate at 0.17 times shareholders' equity.
  • Promoters hold a large stake of 69.03%.

Cons

  • Other income makes up 45% of profit before tax.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Fabtech Technologies Limited

Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.

Employees
186
Head office
Mumbai

Peer comparison

HealthcareHealth Information Services

S.No.CompanyCMP ₹P/EMar Cap ₹ CrDiv Yld %NP Qtr ₹ CrQtr Profit Var %Sales Qtr ₹ CrQtr Sales Var %ROCE %
1.Fabtech Technologies130.3010.65790.454—7510.2611.8
2.Indegene598.3036.014,4090.38116-0.171,06339.7315.3
Median: 2 Co.364.3023.37,4940.4260-0.1756925.0013.6

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ CrJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
681896315975
741657413671
Operating Profit-624-11224
OPM %-9%13%-18%14%6%
147103
Interest12111
Depreciation13111
Profit before tax-625-7305
13%26%19%
-622-6224
EPS in Rs-1.896.79-1.565.750.95
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ CrMar 2026TTM
Sales411486
376447
Operating Profit3539
OPM %9%8%
2124
Interest45
Depreciation57
Profit before tax4853
21%21%
3843
EPS in Rs10.0011.93

Compounded Sales Growth

TTM:
1%

Compounded Profit Growth

TTM:
32%

Stock Price CAGR

1 Year:
-29%

Return on Equity

4 Years:
23%
Last Year:
13%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital333244
Reserves86129141375
35138470
89125170201
Total Liabilities214269427691
465655
210264370636
Total Assets214269427691

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
-1460-360
2-30-20-112
12-1236190
Net Cash Flow-018-2078
Free Cash Flow-1459-61-4

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

RatioMar 2023Mar 2024Mar 2025Mar 2026
ROE24.4%24.6%30.5%12.9%
ROCE33.3%28.0%30.9%11.8%
Operating margin10.7%14.8%11.9%7.7%
Net margin11.2%12.0%14.4%9.4%
Debt / equity0.400.100.480.17
Current ratio1.481.791.392.29
Debtor days187156171216
Inventory days698811932
Days payable215195198215
Cash conversion cycle41499233
Working capital days111172100281

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

  • Promoters 69.03%
  • FIIs 0.02%
  • DIIs 2.45%
  • Public 28.49%
%Dec 2025Mar 2026Jun 2026Sep 2026
Promoters68.94%68.94%68.94%69.03%
0.03%0.08%0.02%0.02%
1.99%2.15%2.45%2.45%
29.04%28.83%28.58%28.49%
No. of Shareholders31,75528,62029,40828,336

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Fabtech Technologies

Holder (above 1%)Stake
Mavira Growth Opportunities FundAIF1.17%

As named in the shareholding pattern for Sep 2026 filed with NSE. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

None filed recently.

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date
17 Aug 2026
Latest quarter
30 Jun 2026
Financial year end
31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an accountHow it works

Latest news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Fabtech Technologies Limited

What is the share price of Fabtech Technologies Limited today?
Fabtech Technologies Limited (FABTECH) last traded at ₹130.30 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.
What is the market cap of Fabtech Technologies Limited?
About ₹579 crore at the latest price.
What is the P/E ratio of Fabtech Technologies Limited?
About 10.6 times its earnings over the last 12 months.
Is Fabtech Technologies Limited a good investment?
We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.
How can I buy Fabtech Technologies Limited shares?
You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.
Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).
Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

  • 100% free
  • No obligation
  • Reply within 2 hours
+91
Join 2,000+ investors who plan with Plenitude
Your details are private and never shared.
WhatsApp Book free call